Universe Pharmaceuticals (UPC) Other Accumulated Expenses (2020 - 2025)

Universe Pharmaceuticals (UPC) has 6 years of Other Accumulated Expenses data on file, last reported at $446.5 million in Q3 2025.

• For the quarter ending Q3 2025, Other Accumulated Expenses rose 525247.06% year-over-year to $446.5 million; the trailing twelve-month figure through Sep 2025 stood at $446.5 million (up 525247.06% YoY), and the FY2025 full-year result was $446.5 million, up 525247.06% from the prior year.
• Other Accumulated Expenses rose to $446.5 million in Q3 2025, from $85000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $446.5 million in Q3 2025 to a low of $7293.0 in Q1 2022.
• A 5-year average of $57.7 million and a median of $2.0 million in 2022 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses plunged 100.0% in 2021 and jumped 525247.06% in 2025, its largest moves.
• Tracing UPC's Other Accumulated Expenses over 5 years: stood at $105212.0 in 2021, then soared by 3111.86% to $3.4 million in 2022, then plunged by 84.02% to $540096.0 in 2023, then sank by 84.26% to $85000.0 in 2024, then jumped by 525247.06% to $446.5 million in 2025.
• Business Quant data shows UPC's Other Accumulated Expenses at $446.5 million in Q3 2025, $85000.0 in Q3 2024, and $5.5 million in Q1 2024.